Summary. Conscious male rhesus monkeys were given epinephrine bitartrate (1 ~g/kg.min) through a catheter implanted in the right internal jugular vein. Blood samples were taken from the portal vein through another catheter before, during, and after a 15-minute-long jugular infusion. Sugar in the plasma rose during, and was still high 10 rain after the infusion, while mean immunereactive insulin decreased during the infusion and rose dramatically after its termination. Ergotamine tartrate (14 ~g/kg.min) while not preventing a rise in plasma sugar concentration, inhibited the expected insulin decrease during epinephrine infusion.
mentait fortement quand die 6tait terminde. Alors que le tartrate d'ergotamine (14 ~g/kg.min) n'emp@ehait pas l'augmentation de la concentration du sucre du plasma, il inhibait la diminution attendue de l'insuline, pendant l'infusion d'adrdnaline.
Introduction
Investigators have shown that epinephrine prevents a glucose-stimulated rise in immunoreactive insulin (II~I) in vitro [1] , and in the systemic venous plasma of the conscious monkey [3] and the serum of man [7] . Because of the possibility that epinephrine-induced changes in hepatic insulin degradation might influence systemic, venous II~I concentrations, the examination of It~I concentration changes in the portal vein was undertaken. By sampling from the portal vein the effect of 1 ~g/kg.min of epinephrine 1 on insulin release from the pancreas could be more accurately inferred from changes in plasma concentrations. Because of the implications of epinephrine as a physiological controller of insulin release, we wondered whether its infusion would result in a lessened increase in IRI in spite of a glucose rise, a continuation at baseline levels, or an actual decrease in portal plasma concentrations.
Ergotamine tartrate has been shown to block epinephrine's inhibitory action upon insulin release in vitro [1] , and "dihydroergotamine opposes epinephrine's * This research was supported in part by Grants: NASA NS-G-(T)-89, USPIIS 6678-2, USPHS AM 09748-02 1 One indication that this dose may be physiological is MAT,M~JAO'S report that hypotension causes the release of 0.997 Mg/kg.min from a single canine adrenal [5] .
injurious effects on islet tissue" in the anesthetized dog [4] . We examined its effect on epinephrine's action in the conscious monkey.
Material and Methods
Male l~hesus (Macaca mulatta) monkeys weighing approximately 5 kg each, were prepared with chronic indwelling right internal jugular and portal vein catheters (polyvinyl chloride I.D. 0.047 inches, from Superenant, Clinton, Mass.) at least ten days before the experiments. This was accomplished under thiopental sodium anaesthesia with aseptic technique. The portal vein catheter was placed in a branch of the superior mesenterie vein, and advanced until contact was made with the liver, it was then retracted 2 cm and sutured in place. The catheters were led under the skin and brought through it lateral to the umbilicus, a point the animals could not reach because of a horizontal plastic plate placed under their arms but above the exit point [9] . The catheters were kept open by programmed infusions of a few drops of saline, containing small amounts of heparin, totaling less than 20 ml of solution each day (about 1000 units of heparin per day).
The monkeys were seated for the duration of the experimental periods in routinely cleaned, continuously lighted, ventilated and closed wooden booths to reduce 1%. E. MILLEt~ and J. S. SOELDNEI~: Suppression of Portal Vextous Insulin Concentration Diabetologia their exposure to varying external stimuli [6] . They were fed Purina Chow biscuits, apples, and oranges, and were given water ad libitum. They were always fed during the afternoon, and fasted for at least 15 h prior to the beginning of an experiment. All experiments were performed between 8 :'45 and 10:15 a.m. in the following way: A control sample was collected from 0847 to 0850 in the same manner as all the samples by allowing blood to drip from the portal catheter, which was held 140 em below the animal's umbilicus. The first of two infusions into the right jugular vein was then begun at a rate of 1 ml per minute. It contained either saline (0.85 g per cent) or ergotamine tartrate 2 (14 ~g/kg.ml) in saline. The second blood sample was obtained during the last three minutes of this ten-minute-long infusion. The second infusion was then begun immediately at the same rate of flow as the first, but containing either saline, epine-2 Ergotamine tartrate If. S.P. Mann l~esearch Laboratories, New York, N.Y. phrine bitartrate S (1 ag/kg.ml), or epinephrine and ergotamine tartrate. The third blood sample was procured from the fifth to the eighth minute of this infusion; the fourth sample from the twelfth to the fifteenth. The second infusion was stopped and the fifth and sixth (final) samples were collected between the seventh to tenth and 42nd to 45th minute after the termination of the infusion. All blood samples were collected in tubes containing approximately 50 units of heparin, the final concentration being less than 20 U per ml blood. They were centrifuged promptly and the plasma was separated and frozen (--20~ until analyzed for insulin and reducing sugars.
Immunoreactive insulin (IRI) was assayed with the double antibody technique [8] using monkey insulin standards, kindly supplied by Mrs. FgANCES Wherry of the Walter Reed Army Institute of Research. The standard curve was developed from known weights of a mixture of Rhesus and Cynomolgus monkey insulin.
It was found that epinephrine bitartrate added to monkey plasma to produce concentrations of 0.004, 0.4, and 4.0 ~g per ml did not affect the determination of IgI concentrations.
Plasma concentrations of reducing sugars were determined with a Technieon Auto-Analyzer using the ferricyanide reduction method [2] . Seven infusions of saline followed by epinephrine, three of ergotamine followed by ergotamine plus epinephrine, and two of saline followed by saline infusions were performed.
Results
The results of the three types of double infusions are shown in Table 1 .
During the saline-epinephrine infusions, portal vein IRI concentrations decreased during the epinephrine portion of the infusion, and rose dramatically at its termination. The mean of the first sample (No. 1) was compared with the mean of the other five samples (No. 2--6) by the T test for paired samples 4. The decreased mean insulin concentration in the third sample was associated with an increase in sugar concentration.
During the first part of the ergotamine-ergotamine plus epinephrine infusions, ergotamine alone caused an insignificant rise in IgI concentration. When ergotamine plus epinephrine were infused, the mean IRI remained above its control value. Mean insulin rose significantly, whereas with epinephrine alone it decreased. This suggests that ergotamine blocked the epinephrine inhibition of insulin release. Mean sugar 3 Epinephrine bitartrate U. S.P. Amend Drug & Chemical Co., New York. This was mixed with saline within 10 rain of the start of its infusion.
4 $ = 5/s/V~ where 5 is the mean of the differences between the paired observations, s is the standard deviation of the differences and n the number of paired samples [i0] . concentration increased during this type of infusion suggesting that there was no effect of the ergotamine on the glycogenolytie effect of epinephrine. In addition, comparison of the IRI, blood sugar relationship suggests that the rising sugar probably was responsible for the rise in IRI.
Discussion
.... Infusion of epinephrine bitartrate in high, but possibly physiological, quantities 1 is associated with a significant decrease in mean IgI concentrations in portal vein plasma. This occurs concomitantly with a significant rise in plasma sugar levels. The addition of ergotamine tartrate to the epinephrine infusion prevents a fall in IRI concentrations.
These results confirm the fmdings of Cooke and PORTE has demonstrated that phentolamine, an alpha-adrenergic blocking agent, prevents the effect of epinephrine on peripheral vein IgI concentrations in man [7] . The ergotamine infusions, which block both alpha and beta-adrenergie receptors, also appear to prevent the IRI decrease engendered by epinephrine [7] . It is of interest that the mean plasma sugar is identical in sample number 4 in both the epinephrine and in the epinephrine plus ergotamine experiments. However, almost three times the concentration of plasma insulin is seen during the latter, suggesting that the rise in plasma glucose is stimulating insulin secretion.
It is unclear whether elevated IRI concentrations of the ergotamine infusions (number two samples) are in part due to alpha-adrenergic blockade of endogenous epinephrine's effect on the pancreas, or whether the insulin rise is secondary to the sugar increase. The latter is probably the case, as one would expect lower, net higher, plasma sugar concentrations if the IRI rise was the primary event. This concNsion is supported by the fact that POt~TE found no rise in peripheral sugar or IRI during an hour-long infusion of phentolamine in a single patient [7] . One explanation of the elevated sugar concentrations of the number two samples and the still elevated sugar and IgI values of the sixth samples is a general sympathetic nervous system activation. Both animals appeared pale during the 1~. E. 1V/XLLE~ and J.S. SOELDNEI~: Suppression of Portal Venous Insulin Concentration ergotamine infusions, and monkey 103 retched shortly after one experiment.
Taken as a whole, these results suggest that epinephrine does play a physiological role in the regulation of insulin release in primates.
